• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测接受自体干细胞移植的多发性骨髓瘤患者血清游离轻链的早期预后价值

Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

作者信息

Özkurt Zübeyde Nur, Sucak Gülsan Türköz, Akı Şahika Zeynep, Yağcı Münci, Haznedar Rauf

机构信息

a Department of Hematology , Gazi University School of Medicine , Ankara , Turkey.

出版信息

Cancer Invest. 2017 Mar 16;35(3):195-201. doi: 10.1080/07357907.2016.1270958. Epub 2017 Jan 23.

DOI:10.1080/07357907.2016.1270958
PMID:28112977
Abstract

We hypothesized the levels of free light chains obtained before and after autologous stem cell transplantation can be useful in predicting transplantation outcome. We analyzed 70 multiple myeloma patients. Abnormal free light chain ratios before stem cell transplantation were found to be associated early progression, although without any impact on overall survival. At day +30, the normalization of levels of involved free light chain related with early progression. According to these results almost one-third reduction of free light chain levels can predict favorable prognosis after autologous stem cell transplantation.

摘要

我们推测,自体干细胞移植前后获得的游离轻链水平可用于预测移植结果。我们分析了70例多发性骨髓瘤患者。发现干细胞移植前游离轻链比例异常与早期进展相关,尽管对总生存期没有任何影响。在第30天,受累游离轻链水平的正常化与早期进展相关。根据这些结果,游离轻链水平降低近三分之一可预测自体干细胞移植后的良好预后。

相似文献

1
Early Prognostic Value of Monitoring Serum Free Light Chain in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.监测接受自体干细胞移植的多发性骨髓瘤患者血清游离轻链的早期预后价值
Cancer Invest. 2017 Mar 16;35(3):195-201. doi: 10.1080/07357907.2016.1270958. Epub 2017 Jan 23.
2
Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse.基于多中心患者的游离轻链比值正常化在多发性骨髓瘤疾病复发中作用的证据
Eur J Haematol. 2016 Feb;96(2):119-27. doi: 10.1111/ejh.12556. Epub 2015 Apr 21.
3
Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation.自体造血干细胞移植后完全缓解的多发性骨髓瘤患者血清免疫球蛋白重/轻链比值的预后影响。
Biol Blood Marrow Transplant. 2012 Jul;18(7):1076-9. doi: 10.1016/j.bbmt.2012.03.004. Epub 2012 Mar 16.
4
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.血清游离轻链检测在多发性骨髓瘤患者中的预后价值
PLoS One. 2016 Nov 28;11(11):e0166841. doi: 10.1371/journal.pone.0166841. eCollection 2016.
5
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.在三项 PETHEMA/GEM 三期临床试验中,血清游离轻链比值和重轻链比值对多发性骨髓瘤的预后价值。
PLoS One. 2018 Sep 7;13(9):e0203392. doi: 10.1371/journal.pone.0203392. eCollection 2018.
6
Serum Free Light Chain Assessment Early After Stem Cell Transplantation as a Prognostic Factor in Multiple Myeloma.
Clin Lymphoma Myeloma Leuk. 2015 Sep;15(9):541-5. doi: 10.1016/j.clml.2015.05.004. Epub 2015 Jun 6.
7
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.高血清游离轻链水平及其对治疗的快速降低定义了一种预后不良的侵袭性多发性骨髓瘤亚型。
Blood. 2007 Aug 1;110(3):827-32. doi: 10.1182/blood-2007-01-067728. Epub 2007 Apr 6.
8
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma.自体干细胞移植一年后多克隆免疫球蛋白的恢复作为多发性骨髓瘤进展和生存的长期预测标志物
Haematologica. 2017 May;102(5):922-931. doi: 10.3324/haematol.2016.158345. Epub 2017 Jan 25.
9
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.多发性骨髓瘤患者外周血中浆细胞和造血祖细胞的同时动员。
J Hematother. 1996 Aug;5(4):339-49. doi: 10.1089/scd.1.1996.5.339.
10
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.通过检测血清游离轻链评估自体干细胞移植后多发性骨髓瘤的肿瘤动力学。
Leuk Lymphoma. 2006 Jan;47(1):21-8. doi: 10.1080/10428190500254216.

引用本文的文献

1
Prognostic and predictive biomarker developments in multiple myeloma.多发性骨髓瘤的预后和预测生物标志物的发展。
J Hematol Oncol. 2021 Sep 23;14(1):151. doi: 10.1186/s13045-021-01162-7.
2
Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.用于评估多发性骨髓瘤患者肿瘤负荷的定量全身磁共振成像:与预后生物标志物的相关性
Quant Imaging Med Surg. 2021 Aug;11(8):3767-3780. doi: 10.21037/qims-20-1361.
3
[Evaluation and comparison of prognostic value of serum free light chain ratio/difference in patients with newly diagnosed multiple myeloma].
[血清游离轻链比值/差值在新诊断多发性骨髓瘤患者中的预后价值评估与比较]
Zhonghua Xue Ye Xue Za Zhi. 2019 Apr 14;40(4):321-326. doi: 10.3760/cma.j.issn.0253-2727.2019.04.011.